In radiotherapy-resistant prostate cancer PCa cells, the treatment with the Gal-3 inhibitor modified citrus pectin (MCP) led to radiosensitization of the cells, increasing ROS production and apoptosis (155). The gene discussed is LGALS3; the disease is prostate carcinoma.